Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
PLoS Negl Trop Dis. 2011 Nov;5(11):e1373. doi: 10.1371/journal.pntd.0001373. Epub 2011 Nov 1.
Antibiotic-resistant Salmonella enterica serovar Paratyphi A, the agent of paratyphoid A fever, poses an emerging public health dilemma in endemic areas of Asia and among travelers, as there is no licensed vaccine. Integral to our efforts to develop a S. Paratyphi A vaccine, we addressed the role of flagella as a potential protective antigen by comparing cell-associated flagella with exported flagellin subunits expressed by attenuated strains.
S. Paratyphi A strain ATCC 9150 was first deleted for the chromosomal guaBA locus, creating CVD 1901. Further chromosomal deletions in fliD (CVD 1901D) or flgK (CVD 1901K) were then engineered, resulting in the export of unpolymerized FliC, without impairing its overall expression. The virulence of the resulting isogenic strains was examined using a novel mouse LD(50) model to accommodate the human-host restricted S. Paratyphi A. The immunogenicity of the attenuated strains was then tested using a mouse intranasal model, followed by intraperitoneal challenge with wildtype ATCC 9150.
Mucosal (intranasal) immunization of mice with strain CVD 1901 expressing cell-associated flagella conferred superior protection (vaccine efficacy [VE], 90%) against a lethal intraperitoneal challenge, compared with the flagellin monomer-exporting mutants CVD 1901K (30% VE) or CVD 1901D (47% VE). The superior protection induced by CVD 1901 with its cell-attached flagella was associated with an increased IgG2a:IgG1 ratio of FliC-specific antibodies with enhanced opsonophagocytic capacity.
Our results clearly suggest that enhanced anti-FliC antibody-mediated clearance of S. Paratyphi A by phagocytic cells, induced by vaccines expressing cell-associated rather than exported FliC, might be contributing to the vaccine-induced protection from S. Paratyphi A challenge in vivo. We speculate that an excess of IgG1 anti-FliC antibodies induced by the exported FliC may compete with the IgG2a subtype and block binding to specific phagocyte Fc receptors that are critical for clearing an S. Paratyphi A infection.
导致甲型副伤寒的耐药性沙门氏菌血清型 Paratyphi A 在亚洲流行地区和旅行者中构成了一个新出现的公共卫生难题,因为目前还没有获得许可的疫苗。在我们努力开发一种甲型副伤寒 A 疫苗的过程中,我们通过比较细胞相关鞭毛与减毒菌株表达的分泌鞭毛蛋白亚单位,研究了鞭毛作为潜在保护性抗原的作用。
首先,我们对 ATCC 9150 株甲型副伤寒 A 进行了染色体 guaBA 基因座缺失,从而构建了 CVD 1901 株。然后,我们对 fliD(CVD 1901D)或 flgK(CVD 1901K)进行了进一步的染色体缺失,导致未聚合的 FliC 分泌,而不损害其整体表达。使用新的小鼠 LD50 模型来适应人类宿主限制的甲型副伤寒 A,来研究同源株的毒力。然后,使用小鼠鼻腔免疫模型测试减毒株的免疫原性,随后用野生型 ATCC 9150 进行腹腔内攻毒。
与表达分泌鞭毛蛋白亚单位的突变株 CVD 1901K(30%疫苗有效性[VE])或 CVD 1901D(47% VE)相比,用表达细胞相关鞭毛的菌株 CVD 1901 进行鼻腔黏膜(鼻腔内)免疫接种的小鼠对致命性腹腔内攻毒具有更好的保护作用(VE,90%)。CVD 1901 与细胞结合的鞭毛诱导的更好保护与 FliC 特异性抗体的 IgG2a:IgG1 比值增加相关,这些抗体具有增强的调理吞噬作用。
我们的结果清楚地表明,通过表达细胞相关而非分泌的 FliC 疫苗诱导的增强的抗 FliC 抗体介导的吞噬细胞清除甲型副伤寒 A,可能有助于体内甲型副伤寒 A 攻毒的疫苗诱导保护。我们推测,由分泌的 FliC 诱导的过多 IgG1 抗 FliC 抗体可能与 IgG2a 亚型竞争,并阻止与清除甲型副伤寒 A 感染至关重要的特定吞噬细胞 Fc 受体结合。